Fortune Sky is Your Go-to Source for the Latest Finance News, Covering Markets, Business, Industries and Internet.
⎯ 《 Fortune • Sky 》

List of All Articles with Tag 'novob dc'

Ozempic Could Be The Next Target of Medicare Price Negotiations
Ozempic Could Be The Next Target of Medicare Price Negotiations
Ozempic, Novo Nordisk A/S’s popular diabetes drug that’s also used for weight loss, could be one of the
2023-08-30 01:52
Weight-Loss Drugs Cost Far More in US Than Other Nations
Weight-Loss Drugs Cost Far More in US Than Other Nations
Sticker shock isn’t slowing Americans’ fervor for weight-loss drugs as a new analysis finds the drugs can cost
2023-08-18 04:54
Slimfast Fades as Dieters Turn to Weight Loss Drugs
Slimfast Fades as Dieters Turn to Weight Loss Drugs
Sales of SlimFast, the meal replacement shakes, have dropped in the US as people turn to new blockbuster
2023-08-16 18:25
European Stocks Lifted by Luxury as China Eases Travel Curbs
European Stocks Lifted by Luxury as China Eases Travel Curbs
European stocks extended gains into a second session, as China’s decision to relax travel curbs offered a lift
2023-08-10 15:55
Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks
Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks
Novo Nordisk A/S said the supply of its blockbuster obesity medicine Wegovy will continue to be restricted in
2023-08-10 14:53
Novo’s Value Surpasses Denmark GDP After Obesity Drug Boost
Novo’s Value Surpasses Denmark GDP After Obesity Drug Boost
Novo Nordisk A/S has just reached another milestone in its meteoric rise: the market value of the Danish
2023-08-09 19:54
Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy
Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy
Wall Street’s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo
2023-08-09 01:47
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the
2023-08-08 18:46
Lilly to Pay Up to $2 Billion for Obesity Startup Versanis
Lilly to Pay Up to $2 Billion for Obesity Startup Versanis
Eli Lilly & Co. will acquire closely held Versanis Bio, a startup developing a drug for obesity and
2023-07-14 23:27
Novo Weight Drugs Probed Over Reports of Suicidal Thoughts
Novo Weight Drugs Probed Over Reports of Suicidal Thoughts
Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number
2023-07-10 20:17
Wegovy Maker Sues US Pharmacy to Block Knock-Off
Wegovy Maker Sues US Pharmacy to Block Knock-Off
Novo Nordisk A/S sued US pharmacies making and selling versions of semaglutide, the active ingredient in Wegovy, the
2023-07-07 08:25
Last Taboo for Hit Obesity Drug Is Asking When to Stop
Last Taboo for Hit Obesity Drug Is Asking When to Stop
Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question
2023-06-30 12:18
«1234»